Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro

Nir Drayman, Krysten A Jones, Sarra-Anne Azizi, Heather M Froggatt, Kemin Tan, Natalia Ivanova Maltseva, Siquan Chen, Vlad Nicolaescu, Steve Dvorkin, Kevin Furlong, Rahul S Kathayat, Mason R Firpo, Vincent Mastrodomenico, Emily A Bruce, Madaline M Schmidt, Robert Jedrzejczak, Miguel A Munoz-Alia, Brooke Schuster, Vishnu Nair, Jason W BottenChristopher B Brooke, Susan C Baker, Bryan C Mounce, Nicholas S Heaton, Bryan C Dickinson, Andrzej Jaochimiak, Glenn Randall, SavaƟ Tay

Research output: Working paper

Fingerprint Dive into the research topics of 'Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro'. Together they form a unique fingerprint.

Medicine & Life Sciences